Michael Savona, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Treadwell Therapeutics
    Topic:
    Consulting or Advisory Role
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Astex Pharmaceuticals
    Topic:
    Research Funding
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Incyte
    Topic:
    Research Funding
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    ALX Oncology
    Topic:
    Research Funding
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Prelude Therapeutics
    Topic:
    Research Funding
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Stake
    Ineligible company:
    Product License - Boehringer-Ingelheim (minority owner)
    Topic:
    Patents, Royalties, Other Intellectual Property
    Date added:
    02/19/2026
    Date updated:
    02/19/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Taiho Oncology
    Topic:
    Travel, Accommodations, Expenses
    Date added:
    02/19/2026
    Date updated:
    02/19/2026

Pages

Return to Faculty Development - 02/26/2026 - Addressing Difficult Questions to Improve Patient Care...